within Pharmacolibrary.Drugs.ATC.G;

model G03GA05
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 8.333333333333334e-06,
    adminDuration  = 600,
    adminMass      = 225 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0089,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>G03GA05</td></tr><td>route:</td><td>subcutaneous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Follitropin alfa is a recombinant human follicle-stimulating hormone (FSH) used primarily in assisted reproductive technology (ART) to induce ovulation in women with infertility problems and stimulate spermatogenesis in men. It is approved for use in fertility treatment.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics in healthy female volunteers after subcutaneous administration of a single dose.</p><h4>References</h4><ol><li><p>Dhillon, S, &amp; Keating, GM (2008). Lutropin alfa. <i>Drugs</i> 68(11) 1529–1540. DOI:<a href=&quot;https://doi.org/10.2165/00003495-200868110-00005&quot;>10.2165/00003495-200868110-00005</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18627209/&quot;>https://pubmed.ncbi.nlm.nih.gov/18627209</a></p></li><li><p>Hoy, SM (2016). XM17 Follitropin Alfa (Ovaleap(®)): A Review in Reproductive Endocrine Disorders. <i>BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy</i> 30(4) 379–386. DOI:<a href=&quot;https://doi.org/10.1007/s40259-016-0183-4&quot;>10.1007/s40259-016-0183-4</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27342604/&quot;>https://pubmed.ncbi.nlm.nih.gov/27342604</a></p></li><li><p>Lammerich, A, et al., &amp; Gertz, B (2015). Phase 1 safety, tolerability, and pharmacokinetic study of single ascending doses of XM17 (recombinant human follicle-stimulating hormone) in downregulated healthy women. <i>International journal of women&#x27;s health</i> 7 707–716. DOI:<a href=&quot;https://doi.org/10.2147/IJWH.S83418&quot;>10.2147/IJWH.S83418</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26213478/&quot;>https://pubmed.ncbi.nlm.nih.gov/26213478</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end G03GA05;
